Coherus BioSciences Inc. (CHRS) Business Metric Overview

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Coherus BioSciences Inc. (CHRS)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

1.45

-0.02 (-1.36%)

At close: Jan 14, 2025, 3:59 PM

1.52

4.83%

Pre-market Jan 15, 2025, 08:52 AM EST

Coherus BioSciences Inc. Revenue Breakdown

Quarter	Sep 30, 2024	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Product and Service, Other Revenue	220.00K	82.50M	87.60M	83.00M
Product and Service, Other Revenue Growth	-99.73%	-5.82%	+5.54%	n/a
Product Revenue	70.55M	n/a	n/a	n/a
Product Revenue Growth	n/a	n/a	n/a	n/a

Revenue by Geography

Quarter	Dec 31, 2019	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Non Us Revenue	n/a	1.56M	1.81M	2.24M
Non Us Revenue Growth	-100.00%	-14.22%	-18.98%	n/a
United States Revenue	356.07M	n/a	188.29M	n/a
United States Revenue Growth	n/a	n/a	n/a	n/a

Operating Expense Breakdown

Quarter	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016	Dec 31, 2015	Sep 30, 2015	Jun 30, 2015	Mar 31, 2015
Selling, General, and Administrative Revenue	34.74M	35.16M	49.73M	48.95M	48.22M	45.14M	49.15M	53.62M	44.83M	51.28M	48.75M	50.05M	39.92M	40.34M	39.39M	37.69M	31.98M	34.05M	35.35M	36.07M	31.83M	36.46M	32.68M	33.84M	25.37M	18.39M	16.58M	14.98M	13.99M	23.53M	18.80M	15.29M	13.64M	11.26M	11.40M	10.97M	10.17M	8.82M	6.09M
Selling, General, and Administrative Revenue Growth	-1.20%	-29.29%	+1.60%	+1.50%	+6.82%	-8.16%	-8.33%	+19.61%	-12.57%	+5.18%	-2.60%	+25.37%	-1.04%	+2.42%	+4.50%	+17.85%	-6.07%	-3.67%	-2.00%	+13.33%	-12.69%	+11.54%	-3.42%	+33.39%	+37.94%	+10.94%	+10.68%	+7.07%	-40.56%	+25.16%	+22.94%	+12.09%	+21.18%	-1.21%	+3.88%	+7.93%	+15.30%	+44.75%	n/a
Research and Development Revenue	21.68M	20.77M	26.96M	25.30M	25.65M	23.27M	34.15M	29.02M	45.81M	41.61M	82.92M	50.76M	54.09M	54.77M	203.49M	44.63M	38.85M	26.17M	33.11M	34.95M	21.57M	18.88M	18.79M	26.66M	31.60M	26.52M	25.45M	31.49M	42.63M	34.50M	53.77M	59.01M	64.57M	65.54M	65.31M	51.43M	68.22M	56.94M	36.47M
Research and Development Revenue Growth	+4.37%	-22.98%	+6.55%	-1.33%	+10.23%	-31.88%	+17.68%	-36.64%	+10.09%	-49.82%	+63.34%	-6.14%	-1.24%	-73.09%	+355.97%	+14.87%	+48.44%	-20.94%	-5.27%	+62.04%	+14.22%	+0.50%	-29.53%	-15.63%	+19.17%	+4.18%	-19.16%	-26.13%	+23.55%	-35.84%	-8.87%	-8.62%	-1.48%	+0.35%	+26.99%	-24.60%	+19.80%	+56.15%	n/a